Tag : clinical research

Clinical Research, Pharma & Healthcare Financing

BioXcel Reports Positive Phase 2 Results for BXCL501

GlobeNewswire
BXCL501 demonstrated clinical benefits and favorable tolerability profile for treatment of opioid withdrawal symptoms Results from this NIDA-funded study support potential future development of BXCL501...
Clinical Research, Pharma & Healthcare Financing

Curanex Announced the Formation of World Class Scientific Advisory Board

GlobeNewswire
Board Includes Former Fortune 100 Pharma Executive and Leading US Medical Research Academic Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a development-stage pharmaceutical...
Clinical Research, Pharma & Healthcare Financing

XyloCor Appoints John Tucker as President and CEO

Business Wire
XyloCor Therapeutics, Inc. (XyloCor or the Company), a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiovascular disease, today announced the appointment of John...
Clinical Research, Pharma & Healthcare Financing

Azenta Acquires UK Biocentre Limited, to Expand Biorepository Capabilities

PR Newswire
Azenta, Inc. (Nasdaq: AZTA), a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited,...
Clinical Research, Pharma & Healthcare Financing

Frontage Laboratories Acquires Teddy Lab

PR Newswire
Frontage Laboratories, Inc. (“Frontage”), a leading global CRO/CDMO, today announced the completion of the acquisition of Teddy Clinical Research Laboratory (Shanghai), Ltd. (“Teddy Lab”), a leading...
Clinical Research, Pharma & Healthcare Financing

NAMI Announces Appointment of Nathan Paul Romano to National Board

PR Newswire
The National Alliance on Mental Illness (NAMI) today announced that Nathan Paul Romano has joined its national board of directors. Romano is a leading mental...
Clinical Research, Pharma & Healthcare Financing

Droplet Biosciences Accelerates Residual Cancer Detection with NVIDIA

PR Newswire
Droplet reduces genomic analysis time using NVIDIA Parabricks, enabling rapid turnaround of test results Droplet Biosciences, a diagnostics company pioneering lymph-based liquid biopsy testing, today announced that...
Clinical Research, Pharma & Healthcare Financing

PureHealth Research Launches “Natural GLP-1 Support” Collection

PR Newswire
PureHealth Research has launched its Natural GLP-1 Support collection, a line of natural GLP-1 supplements offering a needle-free, prescription-free alternative to synthetic injections that can cost thousands of dollars per year. The collection...
Clinical Research, Pharma & Healthcare Financing

FDB Vela, Photon Expand ePrescribing Transparency

PR Newswire
The integration with FDB Vela will broaden pharmacy connectivity and enhance prescription routing to support a more modern, patient-oriented prescribing experience FDB (First Databank, Inc.), the...
Clinical Research, Pharma & Healthcare Financing

Neurogene’s NGN-401 Gets FDA Breakthrough Therapy Status

Business Wire
Breakthrough Therapy designation granted based on interim NGN-401 Phase 1/2 data demonstrating clinically meaningful, durable and multidomain functional improvements for Neurogene’s lead program On track...
Clinical Research, Pharma & Healthcare Financing

Kairos Pharma Signs Term Sheet for Two Oncology Assets

Business Wire
Transformative clinical pipeline transaction will add CL-273, a pan-EGFR inhibitor, and CL-741, a Phase 1-Ready c-MET inhibitor, to Kairos Pharma’s clinical portfolio to target multi-billion...
Clinical Research, Pharma & Healthcare Financing

Argo Biopharma Shares Phase II Results for BW-20805 at AAAAI

PR Newswire
-Poster Presentation Selected as Late Breaking Abstract- Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, has been selected as...
Clinical Research, Pharma & Healthcare Financing

CJ BIO Publishes Study on BiomeNrich POST SZ075 for Skin Health

PR Newswire
CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed journal. The study strengthens the...
Clinical Research, Pharma & Healthcare Financing

Matricelf Reports 2025 Milestones, 2026 Spinal Implant Roadmap

PR Newswire
Matricelf Ltd. (TASE: MTLF), a biotechnology company developing personalized regenerative therapies for spinal cord injury, today issued a shareholder update summarizing its 2025 achievements and...
Clinical Research, Pharma & Healthcare Financing

FDA Grants Full Approval to Pfizer’s BRAFTOVI for Metastatic Colorectal Cancer

Business Wire
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination with cetuximab (marketed...